Albumin-to-alkaline phosphatase ratio: A novel prognostic index for hepatocellular carcinoma

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Chan, Anthony W H ^a   Chan, Stephen L ^a,b   Mo, Frankie K F ^a   Wong, Grace L H ^b   Wong, Vincent W S ^b   Cheung, Yue Sun ^b   Chan, Henry L Y ^b   Yeo, Winnie ^a   Lai, Paul B S ^b   To, Ka Fai ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; BILIRUBIN; SERUM ALBUMIN; TUMOR MARKER;

ADULT; ALBUMIN TO ALKALINE PHOSPHATASE RATIO; ARTICLE; BLOOD CHEMISTRY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL EVALUATION; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEALTH CARE COST; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; SURVIVAL RATE; SYSTEMIC THERAPY; VALIDATION STUDY; AGED; BLOOD; LIVER TUMOR; METABOLISM; PATHOLOGY; SURVIVAL;

ADULT; AGED; ALKALINE PHOSPHATASE; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SERUM ALBUMIN; SURVIVAL ANALYSIS;

EID: 84924217866     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/564057     Document Type: Article

References (20)

1. J. Ferlay, I. Soerjomataram, M. Ervik et al., "Cancer incidence and mortality worldwide: IARC cancer base," GLOBOCAN 2012 v1.0 11, 2014, http://globocan.iarc.fr.
2. C.-L. Chen, C. S. Kabiling, and A. M. Concejero, "Why does living donor liver transplantation flourish in Asia?" Nature Reviews Gastroenterology and Hepatology, vol. 10, no. 12, pp. 746-751, 2013.
3. European Association for the Study of the Liver and European Organisation for Research and Treatment of Cancer, "EASLEORTC clinical practice guidelines: management of hepatocellular carcinoma," Journal of Hepatology, vol. 56, no. 4, pp. 908-943, 2012.
4. G. Torzilli, J. Belghiti, N. Kokudo et al., "Asnapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? An observational study of the HCC east-west study group," Annals of Surgery, vol. 257, no. 5, pp. 929-937, 2013.
5. Y. H. Chun, S. U. Kim, J. Y. Park et al., "Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma," European Journal of Cancer, vol. 47, no. 17, pp. 2568-2575, 2011.
6. The Cancer of the Liver Italian Program (CLIP) Investigators, "A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients," Hepatology, vol. 28, no. 3, pp. 751-755, 1998.
7. S. L. Chan, P. J. Johnson, F. Mo et al., "International validation of the Chinese University Prognostic Index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong study," Chinese Journal of Cancer, vol. 33, no. 10, pp. 481-491, 2014.
8. M. Kudo, H. Chung, S. Haji et al., "Validation of a newprognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score," Hepatology, vol. 40, no. 6, pp. 1396-1405, 2004.
9. S. L. Chan, F.K. F. Mo, P. J. Johnson et al., "Newutility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy," Journal of Clinical Oncology, vol. 27, no. 3, pp. 446-452, 2009.
10. P. S. Kamath, R. H. Wiesner, M. Malinchoc et al., "A model to predict survival in patients with end-stage liver disease," Hepatology, vol. 33, no. 2, pp. 464-470, 2001.
11. S. L. Chan, F.K. F. Mo, P. J. Johnson et al., "Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population," Journal of Gastroenterology and Hepatology, vol. 26, no. 2, pp. 340-347, 2011.
12. S. Ueno, G. Tanabe, K. Sako et al., "Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients," Hepatology, vol. 34, no. 3, pp. 529-534, 2001.
13. J.-N. Vauthey, D. Ribero, E. K. Abdalla et al., "Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniformstaging after surgical treatment," Journal of the American College of Surgeons, vol. 204, no. 5, pp. 1016-1027, 2007.
14. G. Munene, J.-N. Vauthey, and E. Dixon, "Summary of the 2010 AHPBA/SSO/SSAT consensus conference on HCC," International Journal of Hepatology, vol. 2011, Article ID 565060, 4 pages, 2011.
15. F.-D. Huitzil-Melendez, M. Capanu, E. M. O'Reilly et al., "Advanced hepatocellular carcinoma: which staging systems best predict prognosis?" Journal of Clinical Oncology, vol. 28, no. 17, pp. 2889-2895, 2010.
16. Y.-Y. Shao, L.-C. Lu, Z.-Z. Lin et al., "Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems," British Journal of Cancer, vol. 107, no. 10, pp. 1672-1677, 2012.
17. M. Maida, E. Orlando, C. Cammà, and G. Cabibbo, "Staging systems of hepatocellular carcinoma: a review of literature," World Journal of Gastroenterology, vol. 20, no. 15, pp. 4141-4150, 2014.
18. D. H. Esper and W. A. Harb, "The cancer cachexia syndrome: a review of metabolic and clinical manifestations," Nutrition in Clinical Practice, vol. 20, no. 4, pp. 369-376, 2005.
19. S. I. Grivennikov, F. R. Greten, and M. Karin, "Immunity, inflammation, and cancer," Cell, vol. 140, no. 6, pp. 883-899, 2010.
20. M.-C. Yu, K.-M. Chan, C.-F. Lee et al., "Alkaline phosphatase: does it have a role in predicting hepatocellular carcinoma recurrence?" Journal of Gastrointestinal Surgery, vol. 15, no. 8, pp. 1440-1449, 2011.